Evidence map›Paper›PMID 39113386›Full record

ArticleAngewandte Chemie (International ed. in English)2024

Arginine Accelerates Sulfur Fluoride Exchange and Phosphorus Fluoride Exchange Reactions between Proteins.

Li Cao, Bingchen Yu, Paul C Klauser, Pan Zhang, Shanshan Li, Lei Wang

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Design, Synthesis and Anticancer Evaluation of Novel SOMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Covalent tumor anchoring spatially orchestrates antitumor immunity.bioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Mapping the SHP2 Allosteric Pocket With Target-Biased Covalent Fragments.Chembiochem : a European journal of chemical biology · 2026
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Li CaoDepartment of Pharmaceutical Chemistry, the, Cardiovascular Research Institute, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 94158, San Francisco, California, United States.
Bingchen YuDepartment of Pharmaceutical Chemistry, the, Cardiovascular Research Institute, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 94158, San Francisco, California, United States.
Paul C KlauserDepartment of Pharmaceutical Chemistry, the, Cardiovascular Research Institute, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 94158, San Francisco, California, United States.
Pan ZhangDepartment of Pharmaceutical Chemistry, the, Cardiovascular Research Institute, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 94158, San Francisco, California, United States.
Shanshan LiDepartment of Pharmaceutical Chemistry, the, Cardiovascular Research Institute, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 94158, San Francisco, California, United States.
Lei WangDepartment of Pharmaceutical Chemistry, the, Cardiovascular Research Institute, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 94158, San Francisco, California, United States.ORCID 0000-0002-5859-2526

Funding

Research Training in Chemistry and Chemical BiologyT32GM145460 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jason E Gestwicki · 2022 to 2026
$3.1M
Adding New Covalent Bonds to Proteins in Live CellsR01GM118384 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Lei Wang · 2016 to 2026
$3.0M
Covalent Protein Binders for Cancer Research and TherapyR01CA258300 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WANG, LEI · 2021 to 2025
$2.0M
NCI NIH HHS R01 CA258300NCI NIH HHS R01CA258300NIGMS NIH HHS R01 GM118384NIGMS NIH HHS R01GM118384NIGMS NIH HHS T32 GM145460
6 · The paper itself

Abstract

Sulfur fluoride exchange (SuFEx) and phosphorus fluoride exchange (PFEx) click chemistries are advancing research across multiple disciplines. By genetically incorporating latent bioreactive unnatural amino acids (Uaas), these chemistries have been integrated into proteins, enabling precise covalent linkages with biological macromolecules and paving the way for new applications. However, their suboptimal reaction rates in proteins limit effectiveness, and traditional catalytic methods for small molecules are often incompatible with biological systems or in vivo applications. We demonstrated that introducing an arginine adjacent to the latent bioreactive Uaa significantly boosts SuFEx and PFEx reaction rates between proteins. This method is effective across various Uaas, target residues, and protein environments. Notably, it also enables efficient SuFEx reactions in acidic conditions, common in certain cellular compartments and tumor microenvironments, which typically hinder SuFEx reactions. Furthermore, we developed the first covalent cell engager that substantially enhances natural killer cell activation through improved covalent interaction facilitated by arginine. These findings provide mechanistic insights and offer a biocompatible strategy to harness these robust chemistries for advancing biological research and developing new biotherapeutics.

Indexed as

ArginineFluoridesClick ChemistryHumansProteinsSulfinic AcidsSulfur CompoundsArginineFluoridesProteinsSulfinic AcidsSulfur Compoundssulfuryl fluorideClick chemistryCovalent protein drugGenetic code expansionPFExSuFEx

Identifiers

PMID39113386
PMCPMC11560669

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.